| Literature DB >> 27697225 |
David J Carr1, Anna L David2, Raymond P Aitken3, John S Milne3, Pawel P Borowicz4, Jacqueline M Wallace3, Dale A Redmer4.
Abstract
INTRODUCTION: Placental vascularity may be important in the development of fetal growth restriction (FGR). The overnourished adolescent ewe is a robust model of the condition, with ∼50% of offspring demonstrating FGR (birthweight >2 standard deviations below optimally-fed control mean). We studied whether placental vascularity, angiogenesis and glucose transport reflect FGR severity.Entities:
Keywords: Angiogenic factors; Angiopoietin; Fetal growth restriction; Placental vascularity; Sheep
Mesh:
Substances:
Year: 2016 PMID: 27697225 PMCID: PMC5063007 DOI: 10.1016/j.placenta.2016.08.076
Source DB: PubMed Journal: Placenta ISSN: 0143-4004 Impact factor: 3.481
Fig. 1Representative images of immunofluorescence staining of whole placentomes. Representative photomicrograph of section of whole placentome triple stained for vascularity, fetal trophoblast and cell nuclei [upper left] sampled from adolescent sheep dams at 131 ± 0.3 days gestation. Magnification = x200. [upper right] Bright green selection demonstrating fetal portion of placentome (cotyledon) based on lectin FITC staining, [middle right] fetal trophoblast circumscribed with ImagePro Premier software for determining fetal (cotyledon) and maternal (caruncle) compartments. [middle left] CD31 staining (magenta) revealing all blood vessels within placentome. [lower left] blood vessels highlighted (red) within maternal portion of placentome for quantification. [lower right] blood vessels highlighted (red) within fetal portion of the placentome for quantification.
Fetal/placental biometry and umbilical artery Doppler measurements in late gestation.
| Parameter | Control (n = 12) | Non-FGR (n = 10) | FGR (n = 17) | P Value |
|---|---|---|---|---|
| Biparietal diameter (mm) | 54.7 ± 0.29a | 53.9 ± 0.76ab | 52.5 ± 0.43b | |
| Abdominal circumference (mm) | 286 ± 2.4a | 270 ± 4.4b | 259 ± 2.6c | |
| Femur length (mm) | 59.7 ± 1.17a | 59.3 ± 1.2a | 54.4 ± 0.69b | |
| Tibia length (mm) | 77.4 ± 1.07a | 76.4 ± 1.23a | 72.8 ± 1.11b | |
| Renal volume (cm3) | 10.0 ± 0.35a | 8.8 ± 0.51b | 7.7 ± 0.20c | |
| Placentome index (cm2) | 3.7 ± 0.18a | 2.9 ± 0.25b | 2.6 ± 0.18b | |
| Umbilical cord diameter (mm) | 22.9 ± 0.42a | 21.3 ± 0.59b | 19.9 ± 0.19c | |
| Umbilical artery pulsatility index | 0.89 ± 0.04a | 1.12 ± 0.05b | 1.05 ± 0.03b | |
| Umbilical artery resistance index | 0.59 ± 0.01a | 0.66 ± 0.02b | 0.65 ± 0.01b | |
| Umbilical artery systolic to diastolic ratio | 2.28 ± 0.16a | 3.04 ± 0.15b | 2.80 ± 0.09b |
P values shown are for overall ANOVA. Mean values within a row with unlike superscripts are significantly different (p < 0.05 for individual post-hoc comparisons). Data are presented as mean ± SEM.
Pregnancy outcome data from necropsy in late gestation.
| Parameter | Control (n = 12) | Non-FGR (n = 10) | FGR (n = 17) | P Value |
|---|---|---|---|---|
| Fetal weight (g) | 5084 ± 124a | 4824 ± 208a | 3640 ± 117b | |
| Placentome number | 113 ± 5.2a | 107 ± 3.7a | 93 ± 4.0b | |
| Total placentome weight (g) | 521 ± 23.8a | 406 ± 26.9b | 330 ± 23.8c | |
| Average placentome weight (g) | 4.7 ± 0.21a | 3.8 ± 0.22b | 3.6 ± 0.21b | |
| Membrane weight (g) | 281 ± 15.9a | 255 ± 14.9a | 206 ± 10.6b | |
| Total placental weight (g) | 802 ± 36.1a | 661 ± 40.1b | 536 ± 32.8c | |
| Placentome size | ||||
| % <1 cm | 18.3 ± 2.21 | 16.0 ± 1.5 | 18.9 ± 2.8 | 0.728 |
| % 1–2 cm | 16.5 ± 3.0a | 23.6 ± 4.0ab | 25.2 ± 2.0b | 0.050 |
| % 2–5 cm | 62.0 ± 3.0 | 58.9 ± 4.6 | 54.6 ± 3.7 | 0.367 |
| % >5 cm | 3.1 ± 0.8 | 1.4 ± 0.6 | 1.3 ± 0.6 | 0.114 |
| Placentome type | ||||
| % A type | 33.8 ± 8.9 | 36.7 ± 7.3 | 55.4 ± 7.5 | 0.109 |
| % B type | 39.8 ± 5.7 | 40.8 ± 5.9 | 33.2 ± 6.1 | 0.621 |
| % C type | 11.4 ± 3.1 | 5.2 ± 3.8 | 5.5 ± 2.1 | 0.251 |
| % D type | 15.2 ± 3.8 | 17.8 ± 9.2 | 6.2 ± 2.5 | 0.209 |
| Placental efficiency (g fetus/g placenta) | 9.9 ± 0.42a | 12.1 ± 0.53b | 11.7 ± 0.62b | |
| Male-to-female fetal sex ratio | 7:5 | 4:6 | 7:10 | |
P values shown are for overall ANOVA with the single exception of the male-to-female sex ratio, for which the Chi square test was employed – bold indicates p < 0.05. Mean values within a row with unlike superscripts are significantly different (p < 0.05 for individual post-hoc comparisons). Data are presented as mean ± SEM.
Fig. 2Placentome types. Proportions of placentomes types A, B, C and D (according to the classification of Vatnick et al. [17]) sampled from 39 adolescent sheep dams at 131 ± 0.3 days gestation receiving a control intake (Control group, n = 12) or a high intake (overnourished, n = 27) of the same complete diet to induce normal fetoplacental growth or placental and fetal growth restriction (FGR), respectively. Overnourished pregnancies were further subdivided into those subsequently defined as FGR, (fetal weight >2SD below Control group mean, n = 17) or less perturbed with relatively “normal” fetal weight (Non-FGR, n = 10).
Maternal caruncular and fetal cotyledonary mRNA expression of angiogenic ligands/receptors and glucose transporters in late gestation placentomes.
| Placental compartment and gene of interest | Control (n = 12) | Non-FGR (n = 10) | FGR (n = 17) | P value | |
|---|---|---|---|---|---|
| Maternal caruncle | 27.3 ± 3.04a | 23.6 ± 7.45ab | 18.3 ± 1.49b | ||
| 18.8 ± 2.26a | 17.3 ± 5.46a | 9.6 ± 1.13b | |||
| 23.8 ± 2.40a | 21.3 ± 6.72a | 15.1 ± 1.40b | |||
| 28.6 ± 2.82 | 39.6 ± 12.52 | 29.9 ± 2.87 | 0.085 | ||
| 15.7 ± 1.54 | 14.3 ± 4.51 | 11.5 ± 1.27 | 0.154 | ||
| 24.0 ± 1.62a | 25.2 ± 7.96a | 17.1 ± 1.44b | |||
| 14.0 ± 1.17a | 14.9 ± 4.72a | 10.9 ± 0.70b | |||
| 21.6 ± 2.63 | 20.2 ± 6.40 | 19.6 ± 1.76 | 0.785 | ||
| 16.5 ± 1.52 | 13.3 ± 4.20 | 13.8 ± 1.34 | 0.276 | ||
| 18.6 ± 1.14a | 19.0 ± 2.05a | 13.3 ± 0.84b | |||
| 13.2 ± 0.81a | 10.4 ± 0.89b | 9.3 ± 0.68b | |||
| Fetal cotyledon | 26.5 ± 3.53 | 24.3 ± 7.69 | 34.7 ± 3.06 | 0.082 | |
| 15.1 ± 2.42 | 11.0 ± 3.48 | 16.7 ± 1.77 | 0.177 | ||
| 17.0 ± 2.44 | 13.5 ± 4.26 | 21.4 ± 2.12 | 0.096 | ||
| 16.1 ± 2.17 | 15.4 ± 4.87 | 22.1 ± 2.56 | 0.075 | ||
| 9.9 ± 1.07 | 11.6 ± 3.65 | 11.2 ± 0.86 | 0.510 | ||
| 21.9 ± 1.64 | 23.9 ± 7.56 | 22.7 ± 0.90 | 0.654 | ||
| 13.0 ± 0.79a | 18.2 ± 5.76b | 16.2 ± 0.92b | |||
| 14.0 ± 0.79 | 15.5 ± 4.91 | 16.6 ± 0.73 | 0.101 | ||
| 8.9 ± 0.90 | 8.1 ± 2.56 | 8.5 ± 0.45 | 0.735 | ||
| 22.9 ± 1.68 | 25.1 ± 1.57 | 23.7 ± 1.00 | 0.568 | ||
| 20.7 ± 1.31 | 20.8 ± 1.00 | 21.6 ± 0.92 | 0.800 | ||
P values shown are for overall ANOVA – bold indicates p < 0.05. Mean values within a row with unlike superscripts are significantly different (p < 0.05 for individual post-hoc comparisons). Data are presented as mean ± SEM. Abbreviations: VEGFA = vascular endothelial growth factor; FLT1 = fms-related tyrosine kinase 1 (VEGF receptor 1), KDR = kinase insert domain receptor (VEGF receptor 2); NOS3 = nitric oxide synthase 3; FGF2 = fibroblast growth factor 2; ANGPT1 = angiopoietin 1; ANGPT2 = angiopoietin 2; TEK = endothelial tyrosine kinase; GUCY1 = soluble guanylate cyclase (nitric oxide receptor); SLC2A1 = solute carrier family 2 (facilitated glucose transporter) member 1; SLC2A3 = solute carrier family 2 (facilitated glucose transporter) member 3. All data presented are expressed relative to the housekeeping gene 18S.
Fig. 3Maternal and fetal placental vascular indices at 131 days gestation. Placental vascular indices determined separately in maternal caruncle (CAR) and fetal cotyledon (COT) following image analysis of immunostained sections of whole placentomes sampled from adolescent sheep dams at 131 ± 0.3 days gestation who received a control intake (Control group, n = 12) or a high intake (overnourished, n = 27) of the same complete diet to induce normal fetoplacental growth or placental and fetal growth restriction (FGR), respectively. Overnourished pregnancies were further subdivided into those subsequently defined as FGR, (fetal weight >2SD below Control group mean, n = 17) or less perturbed with relatively “normal” fetal weight (Non-FGR, n = 10). Data are presented as mean ± SEM. * indicates p < 0.05 for individual post-hoc comparisons (using test of least significant difference) following one-way analysis of variances. Abbreviations: CAD = capillary area density; CND = capillary number density; CSD = capillary surface density; APC = area per capillary [see Methods for calculations].